IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides

Core Insights - IBI Ag has successfully completed a proof of concept for an AI-driven platform that designs novel bioinsecticide proteins, marking a significant advancement in sustainable agricultural solutions [1] - The new proteins have been validated in insect bioassays, demonstrating efficacy against key agricultural pests while minimizing impact on beneficial insects and the environment [1] - This innovative approach allows for faster market entry and targets previously unattainable insect challenges, optimizing production costs, shelf life, stability, and resiliency [1] Company Overview - IBI Ag is a pioneer in the agri-biotech industry, focusing on sustainable crop protection solutions through proprietary nanobody technology [1] - The company aims to redefine pest management by providing a new mode of action for controlling a broad range of insect pests with minimal ecological footprint [1] - Founded by The Trendlines Group, Prof. Amir Ayali, and Dr. Rony Oren Benaroya, IBI Ag is supported by the Israel Innovation Authority [1] Future Plans - The successful discovery and validation of new bioinsecticide proteins will lead to significant expansion of IBI Ag's development pipeline, with plans for greenhouse and field trials in upcoming growing seasons [1] - IBI Ag is committed to collaborating with agricultural partners and stakeholders to bring these innovative solutions to farmers worldwide [1]